| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/21/2001 | CA2395290A1 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 06/21/2001 | CA2395167A1 Novel 3-oxo-2,1-benzisoxazol-1(3h)-carboxamides for treatment of cns diseases |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2395075A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | CA2394600A1 Methods for producing transgenic animals |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394548A1 Antipsychotic heterocycle compounds |
| 06/21/2001 | CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394504A1 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | CA2394466A1 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | CA2394431A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | CA2394269A1 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 06/21/2001 | CA2394160A1 Human oxidoreductase proteins |
| 06/21/2001 | CA2394130A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 06/21/2001 | CA2394077A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | CA2394012A1 Combination of ginseng and ginkgo to improve cognitive skills |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393838A1 Flat medicinal preparation for transmucosal administration of oxycodon or a comparable active ingredient in the oral cavity, for use in pain therapy and in addiction therapy |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393301A1 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 06/21/2001 | CA2393292A1 Brain specific binding members |
| 06/21/2001 | CA2392992A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | CA2392955A1 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition |
| 06/21/2001 | CA2392953A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors |
| 06/21/2001 | CA2392944A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/20/2001 | EP1108718A2 Trans-6-Acetyl-4S-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3R-ol |
| 06/20/2001 | EP1108047A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108013A2 Genes associated with neurotransmitter processing |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107967A2 Triazolopyridazine derivatives for treating anxiety and enhancing cognition |
| 06/20/2001 | EP1107966A2 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands |
| 06/20/2001 | EP1107965A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107960A1 Pyrazine compounds |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107944A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 06/20/2001 | EP1107940A1 Vitamin d3 mimics |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107778A1 Treatment of disease states |
| 06/20/2001 | EP1107775A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107761A2 4-quinolinemethanol derivatives as purine receptor antagonists (ii) |
| 06/20/2001 | EP1107757A2 Carbamate and urea compositions and neurotrophic uses |
| 06/20/2001 | EP1107755A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/20/2001 | EP1107754A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | EP1107752A1 Pyrrolidine derivatives for vision and memory disorders |
| 06/20/2001 | EP1107748A2 Methods and compositions employing optically pure s(+) vigabatrin |
| 06/20/2001 | EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 06/20/2001 | EP1107745A1 Use of 5ht-6 antagonists |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107733A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP1107732A1 Oral liquid mucoadhesive compositions |
| 06/20/2001 | EP0929515B1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 06/20/2001 | EP0820438B1 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same |
| 06/20/2001 | EP0817621B1 Pharmaceutical composition for transdermic delivery |
| 06/20/2001 | EP0714394B1 Antipsychotic method with thiadiazole and oxadiazole derivatives |
| 06/20/2001 | EP0694304B1 An extract of freshwater mussel, methods of the extraction and uses thereof |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300286A Crystalline form of paroxetine |
| 06/20/2001 | CN1300282A Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300219A Epiallopregnanolone in the treatment of CNS disorders |
| 06/20/2001 | CN1300217A New drug combinations of A N.A.R.I., preferably reboxetine, and pindolol |
| 06/20/2001 | CN1300214A Composition comprising acarnitine and glutathione, useful to incrense the absorption of glutathione and synergize its effects |
| 06/20/2001 | CN1299676A Fatigue relieving medicine for driver |
| 06/20/2001 | CN1299672A Preparation of hemiplegia treating capsule |
| 06/20/2001 | CN1299669A Chinese medicine for treating several kinds of common ailment |
| 06/20/2001 | CN1299660A Sobering up oral liquid and its preparation |
| 06/20/2001 | CN1067391C Piperidyl methyl oxazolidinone |
| 06/20/2001 | CN1067387C 1,2,3,4-tetrahydroquinoxalindione derivative |
| 06/20/2001 | CN1067386C 5-heteroarylindole derivatives as benzodiazepine receptor site agnoists and analagonists |
| 06/20/2001 | CN1067381C New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it |
| 06/20/2001 | CN1067265C Medicine for treating trigeminal neuralgia |
| 06/19/2001 | US6248901 Heterocyclic vinyl ethers |
| 06/19/2001 | US6248785 IL-8 receptor antagonists |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248757 Antiserotonine agents |
| 06/19/2001 | US6248754 Psychological disorders |
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 06/19/2001 | US6248746 Phosphodiesterase (pde-iv) inhibitor for treatment of asthma, allergies, atopic diseases and rhinitis |
| 06/19/2001 | US6248737 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effects |
| 06/19/2001 | US6248729 Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination |
| 06/19/2001 | US6248717 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248528 Drug screening by contacting test compound with human centrin protein and determining whether compound binds to protein |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248358 Bioadhesive progressive hydration tablets and methods of making and using the same |